{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:04:25Z","timestamp":1753877065805,"version":"3.41.2"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:00:00Z","timestamp":1712793600000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The association between use of antipsychotics and COVID-19 outcomes is inconsistent, which may be linked to use of these drugs in age-related diseases. Furthermore, there is little evidence regarding their effect in the nongeriatric population. We aim to assess the association between antipsychotic use and risk of disease progression and hospitalization due to COVID-19 among the general population, stratifying by age.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a population-based, multiple case-control study to assess risk of hospitalization, with cases being patients with a PCR(+) test who required hospitalization and controls being individuals without a PCR(+) test; and risk of progression to hospitalization, with cases being the same as those used in the hospitalization substudy and controls being nonhospitalized PCR(+) patients. We calculated adjusted odds-ratios (aOR) and 95% confidence intervals (CI), both overall and stratified by age.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Antipsychotic treatment in patients younger than 65 years was not associated with a higher risk of hospitalization due to COVID-19 (aOR 0.94 [95%CI\u2009=\u20090.69\u20131.27]) and disease progression among PCR(+) patients (aOR 0.96 [95%CI\u2009=\u20090.70\u20131.33]). For patients aged 65 years or older, however, there was a significant, increased risk of hospitalization (aOR 1.58 [95% CI\u2009=\u20091.38\u20131.80]) and disease progression (aOR 1.31 [95% CI\u2009=\u20091.12\u20131.55]).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The results of our large-scale real-world data study suggest that antipsychotic use is not associated with a greater risk of hospitalization due to COVID-19 and progression to hospitalization among patients younger than 65 years. The effect found in the group aged 65 years or older might be associated with off-label use of antipsychotics.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ijnp\/pyae020","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T05:36:46Z","timestamp":1712813806000},"source":"Crossref","is-referenced-by-count":1,"title":["Outpatient Antipsychotic Use and Severe COVID-19: Avoiding the Impact of Age in a Real-World Data Study"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8315-6463","authenticated-orcid":false,"given":"Samuel","family":"Pintos-Rodr\u00edguez","sequence":"first","affiliation":[{"name":"Department of Public Health, University of Santiago de Compostela , Santiago de Compostela , Spain"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6466-6213","authenticated-orcid":false,"given":"Irene","family":"Visos-Varela","sequence":"additional","affiliation":[{"name":"Department of Public Health, University of Santiago de Compostela , Santiago de Compostela , Spain"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3350-1237","authenticated-orcid":false,"given":"Almudena","family":"Rodr\u00edguez-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Health Research Institute of Santiago de Compostela (IDIS) , Santiago de Compostela , Spain"},{"name":"Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiology and Public Health - CIBERESP) , Madrid , Spain"},{"name":"Department of Public Health, University of Santiago de Compostela , Santiago de Compostela , Spain"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0648-7716","authenticated-orcid":false,"given":"Maruxa","family":"Zapata-Cachafeiro","sequence":"additional","affiliation":[{"name":"Health Research Institute of Santiago de Compostela (IDIS) , Santiago de Compostela , Spain"},{"name":"Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiology and Public Health - CIBERESP) , Madrid , Spain"},{"name":"Department of Public Health, University of Santiago de Compostela , Santiago de Compostela , Spain"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3655-100X","authenticated-orcid":false,"given":"Mar\u00eda","family":"Pi\u00f1eiro-Lamas","sequence":"additional","affiliation":[{"name":"Health Research Institute of Santiago de Compostela (IDIS) , Santiago de Compostela , Spain"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0500-4049","authenticated-orcid":false,"given":"Mar\u00eda Teresa","family":"Herdeiro","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, iBiMED-Institute of Biomedicine, University of Aveiro , Aveiro , Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4703-0234","authenticated-orcid":false,"given":"Rosa Mar\u00eda","family":"Garc\u00eda-\u00c1lvarez","sequence":"additional","affiliation":[{"name":"Santiago de Compostela Health Area, Galician Health Service (Servizo Galego de Sa\u00fade - SERGAS), Santiago de Compostela , Spain"},{"name":"Department of Public Health, University of Santiago de Compostela , Santiago de Compostela , Spain"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5766-8672","authenticated-orcid":false,"given":"Adolfo","family":"Figueiras","sequence":"additional","affiliation":[{"name":"Health Research Institute of Santiago de Compostela (IDIS) , Santiago de Compostela , Spain"},{"name":"Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiology and Public Health - CIBERESP) , Madrid , Spain"},{"name":"Department of Public Health, University of Santiago de Compostela , Santiago de Compostela , Spain"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4349-4947","authenticated-orcid":false,"given":"\u00c1ngel","family":"Salgado-Barreira","sequence":"additional","affiliation":[{"name":"Health Research Institute of Santiago de Compostela (IDIS) , Santiago de Compostela , Spain"},{"name":"Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiology and Public Health - CIBERESP) , Madrid , Spain"},{"name":"Department of Public Health, University of Santiago de Compostela , Santiago de Compostela , Spain"}]}],"member":"286","published-online":{"date-parts":[[2024,4,11]]},"reference":[{"key":"2024043011523510200_CIT0001","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.maturitas.2022.07.008","article-title":"Aging and the COVID-19 pandemic: The inter-related roles of biology, physical wellbeing, social norms and global health systems","volume":"167","author":"Baena","year":"2023","journal-title":"Maturitas"},{"key":"2024043011523510200_CIT0002","doi-asserted-by":"crossref","first-page":"11786","DOI":"10.3390\/ijerph182211786","article-title":"Baseline drug treatments as indicators of increased risk of COVID-19 mortality in Spain and Italy","volume":"18","author":"Bliek-Bueno","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2024043011523510200_CIT0003","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S2215-0366(21)00396-5","article-title":"Antipsychotics and COVID-19: The debate goes on","volume":"8","author":"Boland","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"2024043011523510200_CIT0004","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.recesp.2020.03.027","article-title":"Coronavirus: la emergencia geri\u00e1trica de 2020. Documento conjunto de la Secci\u00f3n de Cardiolog\u00eda Geri\u00e1trica de la Sociedad Espa\u00f1ola de Cardiolog\u00eda y la Sociedad Espa\u00f1ola de Geriatr\u00eda y Gerontolog\u00eda","volume":"73","author":"Bonanad","year":"2020","journal-title":"Rev Esp Cardiol"},{"key":"2024043011523510200_CIT0005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.schres.2021.02.002","article-title":"Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: a retrospective epidemiological study in a representative Spanish population","volume":"229","author":"Canal-Rivero","year":"2021","journal-title":"Schizophr Res"},{"key":"2024043011523510200_CIT0006","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.2174\/1381612821666150619092903","article-title":"Off-label prescribing of antipsychotics in adults, children and elderly individuals: A systematic review of recent prescription trends","volume":"21","author":"Carton","year":"2015","journal-title":"Curr Pharm Des"},{"key":"2024043011523510200_CIT0007","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3233\/JAD-220369","article-title":"Incidence and outcomes of SARS-CoV-2 infection in older adults living with dementia: A population-based cohort study","volume":"89","author":"Cascini","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"2024043011523510200_CIT0008","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3233\/JAD-221093","article-title":"Risk factors for longer-term mortality in discharged patients with dementia and SARS-CoV-2 infection: A matched case-control study","volume":"92","author":"Chen","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"2024043011523510200_CIT0009","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bbi.2023.08.024","article-title":"Risk factors for poor COVID-19 outcomes in patients with psychiatric disorders","volume":"114","author":"Cheng","year":"2023","journal-title":"Brain Behav Immun"},{"key":"2024043011523510200_CIT0010","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ageing\/afw039","article-title":"Development and validation of an electronic frailty index using routine primary care electronic health record data","volume":"45","author":"Clegg","year":"2016","journal-title":"Age Ageing"},{"key":"2024043011523510200_CIT0011","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/acps.13304","article-title":"Mental disorders, psychopharmacological treatments, and mortality in 2150 COVID-19 Spanish inpatients","volume":"143","author":"Diez-Quevedo","year":"2021","journal-title":"Acta Psychiatr Scand"},{"key":"2024043011523510200_CIT0012","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4088\/JCP.7075su1c.04","article-title":"The effects of undertreated chronic medical illnesses in patients with severe mental disorders","volume":"70","author":"Fagiolini","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"2024043011523510200_CIT0013","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.euroneuro.2022.10.004","article-title":"Psychotropic drug repurposing for COVID-19: A systematic review and meta-analysis","volume":"66","author":"Fico","year":"2023","journal-title":"Eur Neuropsychopharmacol"},{"key":"2024043011523510200_CIT0014","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S1888-9891(08)72511-4","article-title":"Attitude toward antipsychotic medication as a predictor of antipsychotic treatment discontinuation in first-episode early-onset psychosis","volume":"1","author":"Fraguas","year":"2008","journal-title":"Rev Psiquiatr Salud Ment"},{"key":"2024043011523510200_CIT0015","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/jgs.17172","article-title":"Trends in antipsychotic prescribing among long-term care residents receiving hospice care","volume":"69","author":"Gerlach","year":"2021","journal-title":"J Am Geriatr Soc"},{"key":"2024043011523510200_CIT0016","doi-asserted-by":"crossref","first-page":"113626","DOI":"10.1016\/j.psychres.2020.113626","article-title":"Anti-viral properties of antipsychotic medications in the time of COVID-19","volume":"295","author":"Girgis","year":"2021","journal-title":"Psychiatry Res"},{"key":"2024043011523510200_CIT0017","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.euroneuro.2017.07.001","article-title":"International trends in antipsychotic use: a study in 16 countries, 2005-2014","volume":"27","author":"H\u00e1lfd\u00e1narson","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"key":"2024043011523510200_CIT0018","doi-asserted-by":"crossref","first-page":"105534","DOI":"10.1016\/j.phrs.2021.105534","article-title":"Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications","volume":"167","author":"Harrison","year":"2021","journal-title":"Pharmacol Res"},{"key":"2024043011523510200_CIT0019","doi-asserted-by":"crossref","first-page":"e444","DOI":"10.1016\/S2468-2667(20)30146-8","article-title":"The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study","volume":"5","author":"Hewitt","year":"2020","journal-title":"Lancet Public Health"},{"key":"2024043011523510200_CIT0020","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1017\/S2045796021000159","article-title":"Use of antipsychotics in Denmark 1997-2018: a nation-wide drug utilisation study with focus on off-label use and associated diagnoses","volume":"30","author":"H\u00f8jlund","year":"2021","journal-title":"Epidemiol Psychiatr Sci"},{"key":"2024043011523510200_CIT0021","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1186\/1471-2458-13-1030","article-title":"Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications","volume":"13","author":"Huber","year":"2013","journal-title":"BMC Public Health"},{"key":"2024043011523510200_CIT0022","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12877-023-03730-7","article-title":"Prevalence and association of frailty with SARS-CoV-2 infection in older adults in Southern Switzerland-Findings from the Corona Immunitas Ticino Study","volume":"23","author":"Jiang","year":"2023","journal-title":"BMC Geriatr"},{"key":"2024043011523510200_CIT0023","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1176\/ps.2010.61.2.130","article-title":"Off-label use of second-generation antipsychotic agents among elderly nursing home residents","volume":"61","author":"Kamble","year":"2010","journal-title":"Psychiatr Serv"},{"key":"2024043011523510200_CIT0024","doi-asserted-by":"crossref","first-page":"100896","DOI":"10.1016\/j.eclinm.2021.100896","article-title":"Clinical frailty scale as a point of care prognostic indicator of mortality in COVID-19: a systematic review and meta-analysis","volume":"36","author":"Kastora","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2024043011523510200_CIT0025","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/schbul\/sbaa051","article-title":"The COVID-19 global pandemic: implications for people with schizophrenia and related disorders","volume":"46","author":"Kozloff","year":"2020","journal-title":"Schizophr Bull"},{"key":"2024043011523510200_CIT0026","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/s12888-022-04026-7","article-title":"Factors associated with COVID-19 infection among a national population of individuals with schizophrenia or schizoaffective disorder in the United States","volume":"22","author":"Liberman","year":"2022","journal-title":"BMC Psychiatry"},{"key":"2024043011523510200_CIT0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2318-2-1","article-title":"Frailty, fitness and late-life mortality in relation to chronological and biological age","volume":"2","author":"Mitnitski","year":"2002","journal-title":"BMC Geriatr"},{"key":"2024043011523510200_CIT0028","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1001\/jamapsychiatry.2021.2503","article-title":"Association between antipsychotic use and COVID-19 mortality among people with serious mental illness","volume":"78","author":"Nemani","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"2024043011523510200_CIT0029","doi-asserted-by":"crossref","first-page":"e2210743","DOI":"10.1001\/jamanetworkopen.2022.10743","article-title":"Association between the use of psychotropic medications and the risk of COVID-19 infection among long-term inpatients with serious mental illness in a New York State\u2013wide psychiatric hospital system","volume":"5","author":"Nemani","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2024043011523510200_CIT0030","first-page":"226","article-title":"Prevalence of frailty at population level in European ADVANTAGE Joint Action Member States: a systematic review and meta-analysis","volume":"54","author":"O\u2019Caoimh","year":"2018","journal-title":"Ann Ist Super Sanita"},{"key":"2024043011523510200_CIT0031","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ageing\/afaa219","article-title":"Prevalence of frailty in 62 countries across the world: A systematic review and meta-analysis of population-level studies","volume":"50","author":"O\u00b4Caoimh","year":"2021","journal-title":"Age Ageing"},{"key":"2024043011523510200_CIT0032","doi-asserted-by":"crossref","first-page":"173553","DOI":"10.1016\/j.ejphar.2020.173553","article-title":"Antiviral activity of chlorpromazine, fluphenazine, perphenazine, prochlorperazine, and thioridazine towards RNA-viruses. A review","volume":"887","author":"Otr\u0119ba","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"2024043011523510200_CIT0033","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.3390\/ijerph17145171","article-title":"EpiChron Group null (2020) baseline chronic comorbidity and mortality in laboratory-confirmed COVID-19 cases: results from the PRECOVID Study in Spain","volume":"17","author":"Poblador-Plou","year":"5171","journal-title":"Int J Environ Res Public Health"},{"key":"2024043011523510200_CIT0034","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12874-019-0695-y","article-title":"Bias in pharmacoepidemiologic studies using secondary health care databases: a scoping review","volume":"19","author":"Prada-Ramallal","year":"2019","journal-title":"BMC Med Res Methodol"},{"key":"2024043011523510200_CIT0035","doi-asserted-by":"crossref","first-page":"104324","DOI":"10.1016\/j.archger.2020.104324","article-title":"Clinical frailty scale and mortality in COVID-19: a systematic review and dose-response meta-analysis","volume":"93","author":"Pranata","year":"2021","journal-title":"Arch Gerontol Geriatr"},{"key":"2024043011523510200_CIT0036","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.schres.2021.06.019","article-title":"An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses","volume":"233","author":"Prokopez","year":"2021","journal-title":"Schizophr Res"},{"key":"2024043011523510200_CIT0037","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.schres.2022.01.035","article-title":"Olanzapine, risperidone and quetiapine: do these atypical antipsychotics have a protective effect for SARS-CoV-2","volume":"241","author":"Prokopez","year":"2022","journal-title":"Schizophr Res"},{"key":"2024043011523510200_CIT0038","doi-asserted-by":"crossref","first-page":"1134377","DOI":"10.3389\/fmed.2023.1134377","article-title":"Development and validation of an electronic database-based frailty index to predict mortality and hospitalization in a population-based study of adults with SARS-CoV-2","volume":"10","author":"Rebora","year":"2023","journal-title":"Frontiers Med"},{"key":"2024043011523510200_CIT0039","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/ije\/dyaa140","article-title":"Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort","volume":"49","author":"Reilev","year":"2020","journal-title":"Int J Epidemiol"},{"key":"2024043011523510200_CIT0040","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.schres.2021.12.020","article-title":"An overall protective effect of antipsychotic drugs against COVID-19 seems implausible","volume":"243","author":"Ruiz de Pell\u00f3n-Santamar\u00eda","year":"2022","journal-title":"Schizophr Res"},{"key":"2024043011523510200_CIT0041","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1016\/S2666-7568(21)00006-4","article-title":"Association between Clinical Frailty Scale score and hospital mortality in adult patients with COVID-19 (COMET): an international, multicentre, retrospective, observational cohort study","volume":"2","author":"Sablerolles","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"2024043011523510200_CIT0042","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jclinepi.2004.10.012","article-title":"A review of uses of health care utilization databases for epidemiologic research on therapeutics","volume":"58","author":"Schneeweiss","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"2024043011523510200_CIT0043","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13195-022-01154-w","article-title":"Dementia and psychotropic medications are associated with significantly higher mortality in geriatric patients hospitalized with COVID-19: Data from the StockholmGeroCovid project","volume":"15","author":"Secnik","year":"2023","journal-title":"Alzheimers Res Ther"},{"key":"2024043011523510200_CIT0044","doi-asserted-by":"crossref","first-page":"e233535","DOI":"10.1001\/jamahealthforum.2023.3535","article-title":"Economic burden associated with untreated mental illness in Indiana","volume":"4","author":"Taylor","year":"2023","journal-title":"JAMA Health Forum"},{"key":"2024043011523510200_CIT0045","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.genhosppsych.2023.04.009","article-title":"Antipsychotics modified COVID-19 prevalence in hospitalized patients diagnosed with mental illnesses","volume":"84","author":"Tendilla-Beltr\u00e1n","year":"2023","journal-title":"Gen Hosp Psychiatry"},{"key":"2024043011523510200_CIT0046","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.genhosppsych.2021.05.005","article-title":"Due to their anti-inflammatory, antioxidant and neurotrophic properties, second-generation antipsychotics are suitable in patients with schizophrenia and COVID-19","volume":"71","author":"Tendilla-Beltr\u00e1n","year":"2021","journal-title":"Gen Hosp Psychiatry"},{"key":"2024043011523510200_CIT0047","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jclinepi.2006.08.012","article-title":"Health state information derived from secondary databases is affected by multiple sources of bias","volume":"60","author":"Terris","year":"2007","journal-title":"J Clin Epidemiol"},{"key":"2024043011523510200_CIT0048","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S2215-0366(21)00232-7","article-title":"Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis","volume":"8","author":"Vai","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"2024043011523510200_CIT0049","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s41999-022-00723-4","article-title":"The impact of polypharmacy on 30-day COVID-related mortality in nursing home residents: a multicenter retrospective cohort study","volume":"14","author":"Visser","year":"2023","journal-title":"Eur Geriatr Med"},{"key":"2024043011523510200_CIT0050","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s12888-021-03374-0","article-title":"Off-label use of antipsychotic medications in psychiatric inpatients in China: a national real-world survey","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Psychiatry"},{"key":"2024043011523510200_CIT0051","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"2024043011523510200_CIT0052","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/j.jinf.2020.04.021","article-title":"Risk factors of critical and mortal COVID-19 cases: A systematic literature review and meta-analysis","volume":"81","author":"Zheng","year":"2020","journal-title":"J Infect"}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ijnp\/advance-article-pdf\/doi\/10.1093\/ijnp\/pyae020\/57212271\/pyae020.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijnp\/advance-article-pdf\/doi\/10.1093\/ijnp\/pyae020\/57360578\/pyae020.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijnp\/advance-article-pdf\/doi\/10.1093\/ijnp\/pyae020\/57360578\/pyae020.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T12:46:27Z","timestamp":1714481187000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article\/doi\/10.1093\/ijnp\/pyae020\/7643883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ijnp\/pyae020","relation":{},"ISSN":["1461-1457","1469-5111"],"issn-type":[{"type":"print","value":"1461-1457"},{"type":"electronic","value":"1469-5111"}],"subject":[],"published-other":{"date-parts":[[2024,4,1]]},"published":{"date-parts":[[2024,4,1]]},"article-number":"pyae020"}}